Synergy Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.32K Buy
40
+23
+135% +$3.45K ﹤0.01% 707
2026
Q1
$2.6K Buy
+17
New +$2.61K ﹤0.01% 668
2025
Q1
Sell
-44
Closed -$4.28K 646
2024
Q4
$4.28K Buy
+44
New +$4.69K ﹤0.01% 480

Other funds holding NVS

Synergy Investment Management's NVS Position: Q2 2026 in Review

Synergy Investment Management increased its Novartis (NVS) stake by 135% in Q2 2026, buying an estimated $3.45K and bringing the position to 40 shares worth $6.32K. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Synergy Investment Management first reported a position in NVS in Q4 2024 and has held it in 3 quarters since. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Synergy Investment Management held 40 shares of Novartis worth $6.32K as of Q2 2026.
  • Synergy Investment Management bought 23 Novartis shares in Q2 2026, an estimated $3.45K.
  • Novartis made up ﹤0.01% of Synergy Investment Management's portfolio in Q2 2026, its #707 holding.
  • Synergy Investment Management first reported a position in Novartis in Q4 2024 and has held it in 3 quarters since.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Synergy Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.